{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_2010"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_2010","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Mechanisms of 5-hydroxytryptamine-induced hypotension","abstract":"Chronic serotonin (5-hydroxytryptamine, 5-HT) infusion results in a sustained fall in blood pressure in the sham and deoxycorticosterone acetate (DOCA)-salt rat. The exact mechanism(s) underlying a 5-HT-induced fall in blood pressure are not yet known. We hypothesize that 5-HT lowers blood pressure in a nitric oxide (NO)-dependent manner by reducing total peripheral resistance (TPR), either through a reduction in sympathetic nervous system (SNS) tone and/or direct stimulation of vascular 5-HT receptors. 5-HT (25 &#956;g/kg/min; s.c.) or vehicle was infused to male Sprague Dawley or DOCA-salt hypertensive rats. Mean arterial pressure (MAP) was measured via radiotelemetry. Cardiac output (CO) was measured via aortic flow probes. 5-HT produced a significant reduction in MAP, increase in cardiac output (CO) and stroke volume (SV), and a significant reduction in total peripheral resistance (TPR). Additionally, 5-HT produced a sustained (one-month) fall in blood pressure in the DOCA-salt rat, but did not prevent the development of DOCA-salt hypertension. Isometric contractile force was measured in the sham and DOCA-salt superior mesenteric artery (SMA) to determine whether direct 5-HT receptor activtation was capable of relaxing the SMA. BW 723C86 (5-HT2B), CP 93129 (5-HT1B), and LP-44 (5-HT7) did not relax the SMA from sham or DOCA-salt rats vs. vehicle. Electrical field stimulation (EFS) was used to determine whether 5-HT was acting to inhibit neurogenic contraction in the isolated SMA. EFS-induced contraction was not significantly different in 5-HT incuabted vs. vehicle incuabted SMA under several conditions. Finally, several studies implicate the importance of the serotonin transporter (SERT) in mediating the effects of 5-HT. 5-HT produced a significantly greater fall in MAP in the SERT WT rat vs. the SERT KO rats suggesting a potentially important role for SERT in producing a 5-HT-induced fall in blood pressure. This research fills a gap in our understanding of how 5-HT functions in the cardiovascular system and validates our hypothesis that 5-HT lowers blood pressure through a reduction in total peripherl resistance. However, this research suggests that 5-HT is not acting through direct receptor mediated vascular relxation or through inhibition of NE release at the nerve terminal in the superior mesenteric artery to lower blood pressure.","abstract_html":"Chronic serotonin (5-hydroxytryptamine, 5-HT) infusion results in a sustained fall in blood pressure in the sham and deoxycorticosterone acetate (DOCA)-salt rat. The exact mechanism(s) underlying a 5-HT-induced fall in blood pressure are not yet known. We hypothesize that 5-HT lowers blood pressure in a nitric oxide (NO)-dependent manner by reducing total peripheral resistance (TPR), either through a reduction in sympathetic nervous system (SNS) tone and/or direct stimulation of vascular 5-HT receptors. 5-HT (25 &amp;#956;g/kg/min; s.c.) or vehicle was infused to male Sprague Dawley or DOCA-salt hypertensive rats. Mean arterial pressure (MAP) was measured via radiotelemetry. Cardiac output (CO) was measured via aortic flow probes. 5-HT produced a significant reduction in MAP, increase in cardiac output (CO) and stroke volume (SV), and a significant reduction in total peripheral resistance (TPR). Additionally, 5-HT produced a sustained (one-month) fall in blood pressure in the DOCA-salt rat, but did not prevent the development of DOCA-salt hypertension. Isometric contractile force was measured in the sham and DOCA-salt superior mesenteric artery (SMA) to determine whether direct 5-HT receptor activtation was capable of relaxing the SMA. BW 723C86 (5-HT2B), CP 93129 (5-HT1B), and LP-44 (5-HT7) did not relax the SMA from sham or DOCA-salt rats vs. vehicle. Electrical field stimulation (EFS) was used to determine whether 5-HT was acting to inhibit neurogenic contraction in the isolated SMA. EFS-induced contraction was not significantly different in 5-HT incuabted vs. vehicle incuabted SMA under several conditions. Finally, several studies implicate the importance of the serotonin transporter (SERT) in mediating the effects of 5-HT. 5-HT produced a significantly greater fall in MAP in the SERT WT rat vs. the SERT KO rats suggesting a potentially important role for SERT in producing a 5-HT-induced fall in blood pressure. This research fills a gap in our understanding of how 5-HT functions in the cardiovascular system and validates our hypothesis that 5-HT lowers blood pressure through a reduction in total peripherl resistance. However, this research suggests that 5-HT is not acting through direct receptor mediated vascular relxation or through inhibition of NE release at the nerve terminal in the superior mesenteric artery to lower blood pressure.","abstract_has_math":false,"creators":["Davis, Robert Patrick"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Watts, Stephanie W.","Fink, Gregory","Dorrance, Anne","Crockett, Elahe"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011","date_published":"2011","updated_at":"2026-11-18T17:43:35Z","subjects":["Serotonin--Physiological effect","Hypotension"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:2010","isbn:9781124718552","isbn:1124718559","oclc:931842734","umi:3460272","local:Davis_grad.msu_0128D_10467"],"render_values":[{"text":"etd:2010","href":null,"code":true},{"text":"isbn:9781124718552","href":null,"code":true},{"text":"isbn:1124718559","href":null,"code":true},{"text":"oclc:931842734","href":null,"code":true},{"text":"umi:3460272","href":null,"code":true},{"text":"local:Davis_grad.msu_0128D_10467","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/5122-j009","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/5122-j009","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_2010","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Watts, Stephanie W.","Fink, Gregory","Dorrance, Anne","Crockett, Elahe"]},{"key":"dc:creator","label":"Author","values":["Davis, Robert Patrick"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2011"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Serotonin--Physiological effect","Hypotension"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:2010","isbn:9781124718552","isbn:1124718559","oclc:931842734","umi:3460272","local:Davis_grad.msu_0128D_10467","https://doi.org/doi:10.25335/5122-j009"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Chronic serotonin (5-hydroxytryptamine, 5-HT) infusion results in a sustained fall in blood pressure in the sham and deoxycorticosterone acetate (DOCA)-salt rat. The exact mechanism(s) underlying a 5-HT-induced fall in blood pressure are not yet known. We hypothesize that 5-HT lowers blood pressure in a nitric oxide (NO)-dependent manner by reducing total peripheral resistance (TPR), either through a reduction in sympathetic nervous system (SNS) tone and/or direct stimulation of vascular 5-HT receptors. 5-HT (25 &#956;g/kg/min; s.c.) or vehicle was infused to male Sprague Dawley or DOCA-salt hypertensive rats. Mean arterial pressure (MAP) was measured via radiotelemetry. Cardiac output (CO) was measured via aortic flow probes. 5-HT produced a significant reduction in MAP, increase in cardiac output (CO) and stroke volume (SV), and a significant reduction in total peripheral resistance (TPR). Additionally, 5-HT produced a sustained (one-month) fall in blood pressure in the DOCA-salt rat, but did not prevent the development of DOCA-salt hypertension. Isometric contractile force was measured in the sham and DOCA-salt superior mesenteric artery (SMA) to determine whether direct 5-HT receptor activtation was capable of relaxing the SMA. BW 723C86 (5-HT2B), CP 93129 (5-HT1B), and LP-44 (5-HT7) did not relax the SMA from sham or DOCA-salt rats vs. vehicle. Electrical field stimulation (EFS) was used to determine whether 5-HT was acting to inhibit neurogenic contraction in the isolated SMA. EFS-induced contraction was not significantly different in 5-HT incuabted vs. vehicle incuabted SMA under several conditions. Finally, several studies implicate the importance of the serotonin transporter (SERT) in mediating the effects of 5-HT. 5-HT produced a significantly greater fall in MAP in the SERT WT rat vs. the SERT KO rats suggesting a potentially important role for SERT in producing a 5-HT-induced fall in blood pressure. This research fills a gap in our understanding of how 5-HT functions in the cardiovascular system and validates our hypothesis that 5-HT lowers blood pressure through a reduction in total peripherl resistance. However, this research suggests that 5-HT is not acting through direct receptor mediated vascular relxation or through inhibition of NE release at the nerve terminal in the superior mesenteric artery to lower blood pressure.","Thesis (Ph. D.)--Michigan State University. Pharmacology and Toxicology, 2011","Includes bibliographical references (pages 144-152)"]},{"key":"dc:format","label":"Dc Format","values":["xii, 152 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["Mechanisms of 5-hydroxytryptamine-induced hypotension"]}]}],"canonical_facts":{"dc:contributor":["Watts, Stephanie W.","Fink, Gregory","Dorrance, Anne","Crockett, Elahe"],"dc:creator":["Davis, Robert Patrick"],"dc:date":["2011"],"dc:description":["Chronic serotonin (5-hydroxytryptamine, 5-HT) infusion results in a sustained fall in blood pressure in the sham and deoxycorticosterone acetate (DOCA)-salt rat. The exact mechanism(s) underlying a 5-HT-induced fall in blood pressure are not yet known. We hypothesize that 5-HT lowers blood pressure in a nitric oxide (NO)-dependent manner by reducing total peripheral resistance (TPR), either through a reduction in sympathetic nervous system (SNS) tone and/or direct stimulation of vascular 5-HT receptors. 5-HT (25 &#956;g/kg/min; s.c.) or vehicle was infused to male Sprague Dawley or DOCA-salt hypertensive rats. Mean arterial pressure (MAP) was measured via radiotelemetry. Cardiac output (CO) was measured via aortic flow probes. 5-HT produced a significant reduction in MAP, increase in cardiac output (CO) and stroke volume (SV), and a significant reduction in total peripheral resistance (TPR). Additionally, 5-HT produced a sustained (one-month) fall in blood pressure in the DOCA-salt rat, but did not prevent the development of DOCA-salt hypertension. Isometric contractile force was measured in the sham and DOCA-salt superior mesenteric artery (SMA) to determine whether direct 5-HT receptor activtation was capable of relaxing the SMA. BW 723C86 (5-HT2B), CP 93129 (5-HT1B), and LP-44 (5-HT7) did not relax the SMA from sham or DOCA-salt rats vs. vehicle. Electrical field stimulation (EFS) was used to determine whether 5-HT was acting to inhibit neurogenic contraction in the isolated SMA. EFS-induced contraction was not significantly different in 5-HT incuabted vs. vehicle incuabted SMA under several conditions. Finally, several studies implicate the importance of the serotonin transporter (SERT) in mediating the effects of 5-HT. 5-HT produced a significantly greater fall in MAP in the SERT WT rat vs. the SERT KO rats suggesting a potentially important role for SERT in producing a 5-HT-induced fall in blood pressure. This research fills a gap in our understanding of how 5-HT functions in the cardiovascular system and validates our hypothesis that 5-HT lowers blood pressure through a reduction in total peripherl resistance. However, this research suggests that 5-HT is not acting through direct receptor mediated vascular relxation or through inhibition of NE release at the nerve terminal in the superior mesenteric artery to lower blood pressure.","Thesis (Ph. D.)--Michigan State University. Pharmacology and Toxicology, 2011","Includes bibliographical references (pages 144-152)"],"dc:format":["xii, 152 pages","application/pdf"],"dc:identifier":["etd:2010","isbn:9781124718552","isbn:1124718559","oclc:931842734","umi:3460272","local:Davis_grad.msu_0128D_10467","https://doi.org/doi:10.25335/5122-j009"],"dc:language":["English"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Serotonin--Physiological effect","Hypotension"],"dc:title":["Mechanisms of 5-hydroxytryptamine-induced hypotension"],"dc:type":["Text","Theses"]},"updated_at":"2026-11-18T17:43:35Z"}